SCHEMBL10502111

SCHEMBL10502111

COc1ccc(-n2[se]c3ccccc3c2=S)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ METAP2 P50579 7/20 0.68
▸ MEN1 O00255 2/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ ATM Q13315 1/20 0.50
▸ MAPT P10636 3/20 0.47
▸ LMNA P02545 2/20 0.47
▸ ALDH1A1 P00352 2/20 0.46
▸ HPGD P15428 2/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ ELANE P08246 1/20 0.45
▸ KDM4E B2RXH2 1/20 0.42
▸ QSOX1 O00391 1/20 0.42
▸ RGS12 O14924 1/20 0.42
▸ PMM2 O15305 1/20 0.42
▸ PLIN1 O60240 1/20 0.42
▸ GMNN O75496 1/20 0.42
▸ BBOX1 O75936 1/20 0.42
▸ TP53 P04637 1/20 0.42
▸ CYBB P04839 1/20 0.42
▸ BCHE P06276 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10502310 0.88 METAP2 (0.52) METAP2MEN1KMT2AATMMAPT
SCHEMBL10501336 0.85 METAP2 (0.50) METAP2MEN1KMT2AMAPTLMNA
SCHEMBL10501830 0.83 METAP2 (0.48) METAP2MEN1KMT2AATMMAPT
SCHEMBL10501877 0.82 METAP2 (0.66) METAP2MEN1KMT2AMAPTLMNA
SCHEMBL10503543 0.82 METAP2 (0.50) METAP2MEN1KMT2AATMMAPT
SCHEMBL10500974 0.81 METAP2 (0.54) METAP2KMT2AMAPTLMNAALDH1A1
SCHEMBL10501589 0.81 METAP2 (0.61) METAP2MEN1KMT2AMAPTLMNA
SCHEMBL10502367 0.81 METAP2 (1.00) METAP2MEN1KMT2AMAPTLMNA
SCHEMBL10501995 0.81 METAP2 (0.47) METAP2
SCHEMBL10501844 0.79 METAP2 (0.66) METAP2MEN1KMT2AMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0154851-B1 BENZISOSELENAZOLETHIONES,PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL PRODUCTS CONTAINING THESE COMPOUNDS A. Nattermann & Cie. GmbH (DE) 1989-08-02 — — EP disclosed
US-4711961-A Benzisoselenazolethiones and process for the treatment of various diseases in humans A. NATTERMANN & CIE GMBH (DE) 1987-12-08 — — US disclosed
EP-0154851-A1 Benzisoselenazolethiones,process for their preparation and pharmaceutical products containing these compounds A. Nattermann & Cie. GmbH (DE) 1985-09-18 — — EP disclosed
Send feedback